申请人:Enanta Pharmaceuticals, Inc.
公开号:US20200361920A1
公开(公告)日:2020-11-19
The present invention discloses compounds of Formula (I), and pharmaceutically acceptable salts and esters thereof:
pharmaceutical compositions comprising these compounds and methods of using these compounds to treat or prevent a disease or disorder mediated as FXR modulators. Specifically, the present invention relates to isoxazole derivatives useful as agonists for FXR, and methods for their preparation and use.